$1.35 Billion is the total value of Ridgeback Capital Investments LLC's 24 reported holdings in Q3 2007. The portfolio turnover from Q2 2007 to Q3 2007 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2007 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2007-11-13
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Biodel Inc | November 26, 2007 | 1,530,000 | 7.6% |
| Chelsea Therapeutics International, Ltd. | November 13, 2007 | 2,835,000 | 9.5% |
| MOMENTA PHARMACEUTICALS INC | May 21, 2007 | 1,904,826 | 5.2% |
| Adams Respiratory Therapeutics, Inc. | April 30, 2007 | 1,831,150 | 5.2% |
| AVANIR PHARMACEUTICALS | April 20, 2007 | 2,000,050 | 5.1% |
| ISOLAGEN INC | March 30, 2007 | 2,573,315 | 8.5% |
| ACADIA PHARMACEUTICALS INC | March 19, 2007 | 1,700,000 | 5.7% |
| AVIGEN INC \DE | March 05, 2007 | 1,253,707 | 5.0% |
| BIODELIVERY SCIENCES INTERNATIONAL INC | March 05, 2007 | 700,000 | 5.0% |
| NUVELO INC | February 14, 2007 | ? | ? |
View Ridgeback Capital Investments LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-NT | 2024-02-14 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
| 13F-NT | 2023-05-15 |
| 13F-NT | 2023-02-14 |
| 13F-NT | 2022-11-14 |
| 13F-NT | 2022-08-15 |
| 13F-NT | 2022-05-16 |
| 13F-NT | 2022-02-14 |
| 13F-NT | 2021-11-15 |
View Ridgeback Capital Investments LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.